Idarubicin in sequential combination with cytosine arabinoside in the treatment of relapsed and refractory patients with acute non-lymphoblastic leukemia-Reference-Cited by-同舟云学术

Idarubicin in sequential combination with cytosine arabinoside in the treatment of relapsed and refractory patients with acute non-lymphoblastic leukemia

Published:1987-07 Issue:7 Volume:23 Page:1041-1045
ISSN:0277-5379
Container-title:European Journal of Cancer and Clinical Oncology
language:en
Short-container-title:European Journal of Cancer and Clinical Oncology

Author:

Lambertenghi-Deliliers Giorgio,Maiolo Anna Teresa,Annaloro Claudio,Cortelezzi Agostino,Pogliani Enrico,Ganzina Fabrizio,Polli Elio E.

Publisher

Elsevier BV

Subject

Oncology

Reference15 articles.

1. Acute myelogenous leukemia: current status of therapy in adults;Foon,1984

2. Antileukemic activity and cardiac toxicity of 4-demethoxydaunorubicin (4-DMD) in mice;Casazza,1979

3. Antileukemic activity of 4-demethoxydaunorubicin in mice;Casazza;Tumori,1980

4. Idarubicin (4-demethoxydaunorubicin);Ganzina,1986

5. Idarubicin in the treatment of acute leukemia: phase I, II and III studies;Berman,1986

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The effects of idarubicin versus other anthracyclines for induction therapy of patients with newly diagnosed leukaemia;Cochrane Database of Systematic Reviews;2015-06-03

2. Idarubicin compared to other anthracyclines for treatment of newly diagnosed acute myeloid leukaemia;Cochrane Database of Systematic Reviews;2013-03-28

3. Anthracycline dose intensification in young adults with acute myeloid leukemia;Therapeutic Advances in Hematology;2011-11-02

4. Idarubicin in combination with intermediate-dose cytarabine in the treatment of refractory or relapsed acute leukemias*;European Journal of Haematology;2009-04-24

5. A Systematic Overview of Chemotherapy Effects in Acute Myeloid Leukaemia;Acta Oncologica;2001-03-01